Search by Drug Name or NDC
NDC 50090-4959-00 .Insulin Aspart Protamine and Insulin Aspart 100 [iU]/mL Details
.Insulin Aspart Protamine and Insulin Aspart 100 [iU]/mL
.Insulin Aspart Protamine and Insulin Aspart is a SUBCUTANEOUS INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is INSULIN ASPART.
Product Information
| NDC | 50090-4959 |
|---|---|
| Product ID | 50090-4959_e7306eaf-dfee-4768-9ede-fcc751dc336e |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | .Insulin Aspart Protamine and Insulin Aspart |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | insulin aspart |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SUSPENSION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | [iU]/mL |
| Substance Name | INSULIN ASPART |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Insulin Analog [EPC], Insulin [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA021172 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-4959-00 (50090495900)
| NDC Package Code | 50090-4959-0 |
|---|---|
| Billing NDC | 50090495900 |
| Package | 5 SYRINGE, PLASTIC in 1 CARTON (50090-4959-0) / 3 mL in 1 SYRINGE, PLASTIC |
| Marketing Start Date | 2020-03-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |